Poulsen Cecilie, Roy Dominic G, Olagnier David
Department of Biomedicine, Aarhus University, Høegh-Guldbergs Gade 10, 8000, Aarhus C, Denmark.
CHUM Research Centre, 900 rue St-Denis, Tour Viger, Montreal, Quebec, H2X 0A9, Canada.
Hum Mol Genet. 2025 Mar 26. doi: 10.1093/hmg/ddae177.
The intersection of immunology and infectious diseases has been revolutionized by the emergence of immunometabolism, highlighting the critical role of metabolic processes in regulating immune responses. In recent years, itaconate alongside its derivatives dimethyl-itaconate (DMI) and 4-octyl-itaconate (4-OI), have received attention for their potent immunomodulatory and antimicrobial properties. This review examines the unique roles of itaconate and its derivatives in modulating immune functions and their implications in infectious diseases. We also explore their structural and functional discrepancies. Notably, while itaconate generally exhibits anti-inflammatory and antimicrobial effects, its derivatives may operate through distinct mechanisms, often exhibiting enhanced electrophilic properties. This review of recent research underscores the potential of itaconate and its derivatives as therapeutic agents, paving the way for future clinical applications in managing inflammation and infectious diseases.
免疫代谢的出现彻底改变了免疫学与传染病的交叉领域,突显了代谢过程在调节免疫反应中的关键作用。近年来,衣康酸及其衍生物二甲基衣康酸(DMI)和4-辛基衣康酸(4-OI)因其强大的免疫调节和抗菌特性而受到关注。本综述探讨了衣康酸及其衍生物在调节免疫功能中的独特作用及其在传染病中的意义。我们还探讨了它们的结构和功能差异。值得注意的是,虽然衣康酸通常具有抗炎和抗菌作用,但其衍生物可能通过不同的机制发挥作用,通常表现出增强的亲电特性。对近期研究的这一综述强调了衣康酸及其衍生物作为治疗剂的潜力,为未来在炎症和传染病管理中的临床应用铺平了道路。